Fitdix Launches First iWatch App that Boosts Men's Sexual Performance
Using Artificial Intelligence, Fitdix will disrupt Big Pharma's Grip on Erectile Dysfunction Medication.
BOCA RATON, Fla., March 31, 2017 /PRNewswire/ -- Simply180, a full service marketing and advertising agency announced today the beta launch of "Fitdix", a new app it developed that uses smartwatch and artificial intelligence technology to help men end their reliance on pharmaceuticals to boost sexual performance and reduce premature ejaculation.
The groundbreaking app was developed not in Silicon Valley, but in suburban Florida. Fitdix's proprietary AI technology will not only disrupt the pharmaceutical industry but usher in a new era in men's health.
The smartwatch app has been in development for two years fueling rampant curiosity. The app logs 100 different techniques to boost arousal, sensation, pleasure and stamina. Users can search for techniques or anonymously share their favorites. Fitdix saves data on motion, pace, intensity, time and calories burned; users can use this data to set new personal goals.
The developers of the app filed a patent for the smartwatch AI technology. Details of the patent are restricted but the company noted the use of the iWatch's accelerometer and the gyroscope to track a user's hand and arm motion (when they move, shake, or tilt) the device. The accelerometer is actually made up of three accelerometers, one for each axis—x, y, and z. Each one measures changes in velocity over time along a linear path. Combining all three accelerometers enables the app to detect device movement in any direction and get the device's current orientation. The gyroscope measures the rate of rotation around the three axes.
The beta version of the app is currently only available for the Apple Watch with plans to release a version for Android Wear in the near future. Premium versions of the app offer personalized training programs and the ability to monitor heart rate zones.
According to Kantar Media, the pharmaceutical industry spent approximately $6 billion on direct-to-consumer (DTC) advertising in 2016, with Eli Lilly and Pfizer leading the way spending more than $250 and $200 million respectively on their leading erectile dysfunction brands.
"Thanks to advancement in artificial intelligence, smartwatch technology and the massive adoption of apps, we developed an app that will really challenge the pharmaceutical industry's dominance in solving men's health and sexual performance issues," said Jason Cohen, CEO of Simply180.
"Through this app, we believe we are on a path for technology and data to help reduce our reliance on prescription and over-the-counter drugs."
According to consumer trials conducted over a 6-month period, users reported the following health benefits:
- 57% experienced a decrease in premature ejaculation
- 76% reported increase in natural erection strength
- 61% reported lasting longer during sex between 18-21 minutes
- 23% experienced a reduction in nasal congestion
- 42% reported a decrease in stress and depression
Fitdix will soon be available for download in the Apple App Store. For more information about the app, visit http://fitdix.com/.
ABOUT
Simply180 is a full-service marketing and advertising agency based in Boca Raton. The agency elevates brands, launches new products and helps clients propel revenue growth through the integration of creative, marketing and technology. This release is an April Fools' release and should be taken as such by readers and the media.
MEDIA CONTACT:
David Haut
Simply180
P: 561-674-0757
E: [email protected]
W: www.simply180.com
SOURCE Simply180
Share this article